what time of day to take retatrutide Before and After: Doctor Reveals Real Results Retatrutide Dosing Guide for Researchers

Understanding these potential contributing factors helps contextualise patient experiences and guides appropriate management

Triple agonists add glucagon receptor activation, which: Increases resting energy expenditure by 8% to 12% (Jall et al., Diabetes Care 2024) Promotes hepatic fat oxidation and reduces steatosis May offset some of the lean mass loss seen with GLP-1 monotherapy (early signal, not yet confirmed in long-term trials) The weight loss ceiling for retatrutide appears to be 24% to 26% based on phase 3 data, though long-term real-world outcomes are not yet available

However, GLP-1's slowing of gastric emptying may slightly reduce absorption of any oral medications, including thyroid therapies

(October 2025)

These drugs mimic a natural hormone in your body

The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice